ReviewCureus2025
Nipah Virus Outbreaks in India: A Comprehensive Update.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The Nipah virus threat in India: Epidemiological trends, risk drivers, and lessons for pandemic preparedness.PLoS pathogens · 2026Review
- Re-emergence of Nipah Virus in Eastern India: Urgent need for enhanced surveillance.New microbes and new infections · 2026Article
- Integrated Risk Matrix and Borda Count Analysis on Importation Risk Assessment of Nipah Virus Infection - China, 1999-2026.China CDC weekly · 2026Article
- Review
- Nipah and chandipura viruses: Emerging neurotropic zoonotic viruses in south asia - a comparative review.Molecular biology reports · 2026Review
- A risk-gate mechanistic-ecological framework for assessing emergence potential of henipa-related viruses.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Nipah virus (NiV) poses a serious threat to public health. This is a result of its high pathogenicity and zoonotic transmission potential. Since its discovery, NiV has been connected to multiple outbreaks with a high death toll, underscoring the need for effective response and surveillance strategies. Transmission of the virus is strongly associated with its natural reservoirs, fruit bats, as habitat decline has increased the likelihood of zoonotic spillovers. For the development of targeted therapeutics, it is essential to ascertain the host's immune reaction to NiV. Although there are now no viable treatments or vaccines, there is hope because promising candidate vaccines are being researched. This article examines the pathophysiology, immune evasion strategies, transmission dynamics, taxonomical position, and structural features of the NiV, with an emphasis on the epidemiology of the virus in India. This study intends to improve understanding of complex viral risks and the effects of public health campaigns by gathering all available data on treatment and preventive techniques. This will ultimately lead to better epidemic planning and response tactics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.